Sale!

RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Qualitative Genetic Test

Original price was: R2,000.Current price is: R1,500.

-25%

The RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Qualitative test is a crucial genetic screening that detects specific chromosomal abnormalities associated with acute myeloid leukemia (AML). For just ZAR 1,500, this advanced Real Time PCR test provides accurate detection of the RUNX1-RUNX1T1 fusion gene, which is vital for early diagnosis and monitoring of AML treatment response. Our test delivers reliable results within 3-4 days, giving you and your healthcare provider the critical information needed for timely medical decisions. At Oracle Genomics, we understand the anxiety that comes with potential blood disorders, which is why we’ve made this essential test accessible and affordable across South Africa. Trust our certified laboratories and experienced medical team to provide the accurate, confidential results you need for peace of mind and proper health management.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

RUNX1-RUNX1T1 Genetic Test | ZAR 1
RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Qualitative Genetic Test
R2,000 Original price was: R2,000.R1,500Current price is: R1,500.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding Your RUNX1-RUNX1T1 Genetic Test

When facing concerns about blood disorders or leukemia, the uncertainty can be overwhelming. At Oracle Genomics, we understand the anxiety that comes with potential genetic abnormalities, which is why we’ve made the RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Qualitative test accessible and affordable for all South Africans. This advanced genetic screening provides crucial insights that could make all the difference in your health journey.

What This Test Detects

The RUNX1-RUNX1T1 test specifically identifies a chromosomal translocation between chromosomes 8 and 21, creating what’s known as the AML1-ETO fusion gene. This genetic abnormality is strongly associated with acute myeloid leukemia (AML), particularly in younger patients. By detecting this specific genetic marker, your healthcare provider can:

  • Confirm or rule out specific subtypes of AML
  • Monitor treatment effectiveness
  • Detect minimal residual disease after treatment
  • Guide personalized treatment decisions

Who Should Consider This Test

This test is particularly important if you’re experiencing symptoms that might indicate blood disorders, or if you have risk factors for leukemia. Consider the RUNX1-RUNX1T1 test if you have:

  • Unexplained fatigue or weakness that doesn’t improve with rest
  • Frequent infections or prolonged recovery from illnesses
  • Unexplained bruising or bleeding tendencies
  • Pale skin, shortness of breath, or dizziness
  • Bone pain or tenderness
  • Family history of blood cancers or genetic disorders
  • Abnormal blood test results suggesting possible leukemia
  • Currently undergoing treatment for AML and need monitoring

Why Early Detection Matters for Your Health

Early detection of the RUNX1-RUNX1T1 fusion gene can significantly impact your treatment outcomes and quality of life. Patients with this specific genetic marker often respond better to certain treatments, making accurate detection crucial for:

  • Personalized Treatment: Knowing your specific genetic profile helps doctors choose the most effective therapies
  • Monitoring Progress: Regular testing helps track treatment response and detect relapse early
  • Peace of Mind: Clear results reduce uncertainty and help you make informed health decisions
  • Better Outcomes: Early intervention often leads to improved survival rates and quality of life

Understanding Your Results

We understand that waiting for genetic test results can be stressful. Our team provides clear, easy-to-understand reports that your healthcare provider will discuss with you. A positive result indicates the presence of the RUNX1-RUNX1T1 fusion gene, which requires immediate consultation with a hematologist or oncologist. A negative result provides reassurance, though your doctor may recommend additional testing based on your symptoms and medical history.

Affordable Pricing for Peace of Mind

Test Option Regular Price Special Price Turnaround Time
RUNX1-RUNX1T1 Qualitative Test ZAR 2,000 ZAR 1,500 3-4 days

Test Details:

  • Sample Type: Bone marrow or Peripheral blood (Transport immediately)
  • Components: EDTA Vacutainer (2ml)
  • Method: Real Time PCR
  • Specialty: General Physician
  • Preparation: Available with Doctor’s prescription (not applicable for surgery, pregnancy, or travel abroad cases)

Nationwide Coverage You Can Trust

Oracle Genomics brings advanced genetic testing to communities across South Africa. With collection centres in Johannesburg, Cape Town, Durban, Pretoria, and nationwide, we make essential healthcare accessible when you need it most. Our certified laboratories and experienced medical team ensure the accuracy and reliability you deserve.

Take Control of Your Health Today

Don’t let uncertainty about genetic risks affect your peace of mind. Early detection through the RUNX1-RUNX1T1 test could be the key to better health outcomes. Our compassionate team is here to support you every step of the way, from booking your test to understanding your results.

Ready to Get Started?

Book Your Test Today: Call us at [Phone Number] or visit our website to schedule your appointment

Walk-in Appointments: Available at all our centres nationwide

Medical Professional Referral: Ask your doctor about the RUNX1-RUNX1T1 test

Your health journey matters. Trust Oracle Genomics for accurate, affordable genetic testing that puts your wellbeing first.